2011

1. Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: Does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay

   Clinical Lymphoma, Myeloma and Leukemia, Vol. 11, Núm. 3, pp. 280-285